Inke participates in CPHI China 2025

Last week, Inke took part in CPHI Shanghai 2025, one of the most important international events in the pharmaceutical calendar. The exhibition brought together global industry leaders and innovators, from advanced research to generic manufacturing, offering a comprehensive view of the entire pharmaceutical supply chain.

Over three intensive days, our team engaged with partners and industry professionals to exchange ideas, discuss regional market trends, and identify new business opportunities.

Key insights from the event:

• A record-breaking edition: CPHI China 2025 featured the highest number of exhibitors since its inception, highlighting the industry’s growing appetite for expansion and diversification across global and regional markets.
• Inhalation APIs on the rise: Inhalation APIs are gaining traction among Chinese manufacturers. Despite increasing competition, Inke remains ahead through its focus on specialization and continuous innovation in this segment.
• Boom in nebulized formulations: The Chinese market is seeing rapid growth in nebulizer-based treatments. This is also driving development in DPI (dry powder inhalers) and pMDI (pressurized metered-dose inhalers), leveraging shared formulation knowledge and experience.
• Differentiation as a strategic priority: Chinese formulation companies are actively pursuing differentiated solutions to protect their position and profitability in increasingly competitive markets. Inke’s portfolio of high-quality APIs and technical expertise is well positioned to support this trend.
• Growing focus on advanced therapies: Biologics and novel small molecules for specialized treatments are receiving more attention from developers, signaling a shift towards innovation-driven pipelines.

As a company committed to high-quality inhalation APIs and strong regulatory expertise, Inke is proud to contribute to advancing pharmaceutical standards and patient outcomes worldwide.

We thank all the partners and professionals we met during the event for their time, collaboration, and shared vision.